A tool for isolating progenitor cells from human heart tissue could lead to heart repair

October 7, 2015
A tool for isolating progenitor cells from human heart tissue could lead to heart repair
The monoclonal antibody C19 recognizes cardiac progenitor cells (green) in human heart tissue. Credit: A*STAR Bioprocessing Technology Institute

A*STAR researchers and colleagues have developed a method to isolate and expand human heart stem cells, also known as cardiac progenitor cells, which could have great potential for repairing injured heart tissue.

Cardiovascular disease is the leading cause of death and debilitating injury in the world today. Heart attacks damage , or 'cardiomyocytes', often leading to irreversible functional damage. A potential treatment option for long-term recovery is to replace the damaged cells with new functional cardiomyocytes through stem cell therapy, which could limit or even reverse the damage.

Early trials on mice treated with stem cells of non-cardiac origin—bone and peripheral , for example—had limited success mainly due to a failure to graft on to the host tissue. However, much interest was sparked by the discovery that the adult heart contains a small population of tissue-specific stem cells. "This 'next generation' stem cell-based therapy using cardiac progenitor cells will allow us to move much closer to getting a robust and effective solution to heart repair" explains Andre Choo from the A*STAR Bioprocessing Technology Institute (BTI).

Previous studies have shown that mouse cardiac progenitor cells isolated and expanded by targeting their surface marker—a protein called 'Stem cell antigen-1', or Sca-1 for short—can efficiently engraft into existing heart tissue and form cardiomyocytes. Cells with similar properties have been found in human heart tissue but the lack of a Sca-1 equivalent in has prevented clinical applications.

Choo, along with Leung Hau Wan (also from the BTI), and other colleagues were determined to find a way to isolate and expand these cells in humans. They found that a monoclonal antibody (C19) was able to recognize the protein GRP78, decorated with a unique sugar moiety on the surface of human cardiac progenitor cells. The antibody could then be used to isolate these cells from both foetal hearts and undergoing differentiation towards cardiomyocytes.

The team was able to expand and stimulate the isolated human cardiac progenitor cells to generate all three cardiac cell types: cardiomyocytes, and , making them an ideal source for cell-based cardiac repair. Compared with that are able to differentiate into many more cell types, "the restricted differentiation lineage of the cardiac progenitor cells will greatly improve the safety aspect of such stem cell therapeutics" says Choo.

Further characterization of human cardiac progenitor cells and their differentiation mechanisms will pave the way for more tools to manipulate them so that their full therapeutic potential may be realized.

Explore further: Research identifies promising tool for cardiac stem cell grafting

More information: "mAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs." Journal of Molecular and Cellular Cardiology 82, 228–237 (2015). dx.doi.org/10.1016/j.yjmcc.2015.02.016

Related Stories

Research identifies promising tool for cardiac stem cell grafting

December 5, 2013
New research by University of Vermont Associate Professor of Medicine Jeffrey Spees, Ph.D., and colleagues has identified a new tool that could help facilitate future stem cell therapy for the more than 700,000 Americans ...

Researchers identify stem-like progenitor cell that exclusively forms heart muscle

June 25, 2015
Future therapies for failing hearts are likely to include stem-like cells and associated growth factors that regenerate heart muscle. Scientists from the Perelman School of Medicine at the University of Pennsylvania have ...

Researchers isolate human muscle stem cells

September 23, 2015
UC San Francisco researchers have successfully isolated human muscle stem cells and shown that the cells could robustly replicate and repair damaged muscles when grafted onto an injured site. The laboratory finding paves ...

Can 'off the shelf' stem cell therapy treat heart failure patients? UB researcher aims to find out

March 16, 2015
After a heart attack, cardiac stem cell therapy stimulates the growth of new heart cells, but exactly how that happens is unclear. The National Institutes of Health has awarded a $2 million grant to a researcher at the University ...

Stem cell study in mice offers hope for treating heart attack patients

February 15, 2012
A UCSF stem cell study conducted in mice suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack. The approach potentially could improve cardiac function, minimize scar size, lead ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.